Show All
Neurogene is headquartered in New York City.
Neurogene is incorporated in the state of Delaware.
Neurogene is traded on the NASDAQ Global Market under the ticker symbol NGNE.
Neurogene will end the fiscal year on December 31st.
Broadridge Corporate Issuer Solutions, LLC serves as Neurogene’s transfer agent.
Shares of Neurogene stock can be purchased by contacting a securities broker of your choice.
You can submit queries to Neurogene’s Investor Relations department by contacting neurogene@argotpartners.com